ABX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ABX is not a strong buy right now for a beginner long-term investor. The stock is trading near its pivot level, technical momentum is mixed to weak, and there is no strong proprietary buy signal. Analyst sentiment is split between Neutral and a recent Buy initiation, but the broader Wall Street view is still cautious. With no recent news catalyst, no insider buying trend, and no current financial quarter data to confirm accelerating fundamentals, the best read is to hold rather than buy aggressively at this price.
ABX closed at 8.97, slightly above the previous close of 8.86, for a 1.24% gain. Technically, the MACD histogram is -0.0629 and still below zero, though contracting, which suggests downside momentum is easing but not reversed. RSI_6 at 42.16 is neutral-to-soft, showing the stock is not oversold enough to strongly attract buyers. Moving averages are converging, pointing to a possible trend transition but not a confirmed uptrend. Price is sitting almost exactly at the pivot of 8.987, with support at 8.422 and resistance at 9.552. The short-term pattern expectation is mixed, with modest near-day upside but weaker weekly and monthly projections.
["Hedge funds are buying, with buying amount up 182.18% over the last quarter.", "A new Buy initiation from Freedom Broker with a $13 price target supports upside potential.", "Piper Sandler raised its price target to $10 from $9.50 after the company posted a core beat and raised 2026 guidance.", "The company increased 2026 adjusted net income guidance midpoint to $103M from $100M."]
["Piper Sandler still keeps a Neutral rating despite the higher target.", "Piper previously cut the target from $11 to $9.50 and downgraded the stock to Neutral, citing valuation.", "No news in the recent week, so there is no fresh event-driven catalyst.", "Insiders are neutral with no significant trading trend over the last month.", "Technical momentum remains weak with a negative MACD and neutral RSI.", "Pattern-based expectations suggest only limited near-term upside and weaker one-month performance."]
The latest quarter financial snapshot was not available due to an error, so there is no reliable quarter-by-quarter revenue or earnings breakdown to assess. The most important recent fundamental takeaway is that management raised 2026 guidance, with adjusted net income midpoint moving to $103M, which indicates improving outlook and operational confidence. However, without the full latest-quarter season financials, the growth picture remains incomplete.
Analyst sentiment is mixed. Piper Sandler raised its price target to $10 from $9.50 on May 8, 2026, but kept a Neutral rating, indicating improving fundamentals but not enough conviction for a bullish stance. On May 6, 2026, Freedom Broker initiated coverage with a Buy rating and a $13 target, which is the most bullish view in the data. Earlier, Piper Sandler had cut the target to $9.50 from $11 and downgraded to Neutral, and before that it had also cited valuation after a strong run. Overall, Wall Street is split: there is upside support from a fresh Buy initiation, but the broader pros-and-cons view remains cautious rather than strongly bullish.
